MIAT in human cancers can act as a competitive endogenous RNA, play the role of miRNA sponge, regulate some signaling pathways, and affect some epigenetic modulators such as histone deacetylases and DNA methyltransferases [16,17,18,19,20]. This evidence concerns the gene MIAT and cancer.